Long-term Safety Study of Kineret® in Patients With Systemic Juvenile Idiopathic Arthritis (SJIA)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
The purpose of the study is to evaluate and characterize long-term safety of Kineret when used in standard clinical practice to treat patients with systemic juvenile idiopathic arthritis (SJIA). The study will be based on already available data from the Pharmachild juvenile idiopathic arthritis (JIA) registry which holds the European Network of Centers for Pharmacoepidemiology and Pharmacovigilance (ENCePP) study seal.
Epistemonikos ID: dbd12e1c9082aad1cc29f6578c44bcdd1dad030d
First added on: May 22, 2024